Search Results

Bone grafting

Pro-Dense LoVisc Injectable Regenerative Graft

Stryker - Wright Medical - Pro-Dense LoVisc injectable regenerative graft is Pro-Dense Graft in a lower viscosity form. Pro-Dense LoVisc allows for easier injectability, improved flowability, and extended working time compared to the original Pro-Dense formulation. Pro-Dense LoVisc graft sets hard, is radiopaque, and regenerates stronger, denser new bone.¹

AlloMatrix

Demineralized Bone Matrix

AlloMatrix is a line of demineralized bone matrix (DBM) bone grafting putties containing OsteoSet surgical-grade calcium sulfate.

Ignite

Injectable Stimulus

Ignite injectable stimulus combines an injectable cellular scaffold, demineralized bone matrix (DBM), and aspirated bone marrow. The combination provides a minimally invasive graft with osteoconductive, osteoinductive, and osteogenic capacity.

FusionFlex

DBM Sponge

FusionFlex is a dehydrated DBM sponge with flexible and resilient handling characteristics and strong hydrophilic absorption properties to support new bone formation with a flexible, osteoinductive scaffold sponge

Tensix

Demineralized Bone Graft

Tensix is a ready-to-use line of demineralized bone matrix (DBM) bone grafting putty available in a convenient pre-hydrated, ambient temperature stored package.

Pro-Stim

Injectable Inductive Graft

Pro-Stim is the next step in composite grafting technology. Built on the Pro-Dense graft platform as a combination of calcium sulfate and calcium phosphate, Pro-Stim adds demineralized bone matrix (DBM) for osteoinductive factor.

Traditional allografts

portfolio

Stryker continues to develop innovative technologies to enhance our spectrum of products, while collaborating with industry-leading tissue organizations to offer a robust portfolio of proprietary spinal grafts, viable bone matrices, demineralized bone matrix products, structural allografts, and large segmental, reconstructive allografts.

X-Ream

Percutaneous Expandable Reamer

Advanced core decompression: Debride more through the same hole with the X-Ream Expandable Reamer

Vitoss

Bone Graft Subsitute

A synthetic bone graft substitute offering a unique interconnected, ultra-porous structure that resembles human cancellous bone.

DBM

Demineralized Bone Matrix

An osteoconductive allograft bone matrix with osteoinductive potential, combined with a reverse phase media carrier to offer enhanced handling properties.

Vitoss BA

Bioactive Bone Graft Substitute

A synthetic bone graft substitute with bioactive glass that has a unique porosity, structure, and chemistry to help drive 3-D regeneration of bone.

Vitoss BA2X

Bioactive Bone Graft Substitute

A synthetic bone graft substitute that has increased levels of bioactive glass compared to Vitoss BA, and has a unique porosity, structure, and chemistry to help drive 3-D regeneration of bone.

Vitoss BBTrauma

Bioactive Bone Graft Substitute

A synthetic bone graft substitute containing a broader range of bioactive glass particle size distribution than other forms of Vitoss, and has a unique porosity, structure, and chemistry to help drive 3D regeneration of bone

Extremity

Procedural Kit

As the leader in foot and ankle surgery, Stryker continues to develop cutting edge technologies that help simplify complex surgery and improve outcomes. The Extremity Procedure Kit provides a system for retrograde drilling for cystic lesions.

Osteolysis

Procedural Kit

The Osteolysis Procedural Kit is a complete, all-in-one procedure kit for the debridement of osteolytic defects. Providing the tools that you need.

Osteoset

Resorbable Beads

OsteoSet resorbable beads are synthetic calcium sulfate beads for bone grafting.

AlloFiber

Demineralized Bone Fibers

AlloFiber is comprised of freeze-dried cortical fibers and can be easily hydrated and mixed with autologous bone, bone marrow aspirate, blood or saline. It is moldable and has a putty-like handling for packing bone voids and gaps.

Pro-Dense

Faster, Stronger, and Denser New Bone.*
Pro-Dense injectable regenerative graft has a unique triphasic resorption profile that provides an ideal environment for the direct deposition of bone by binding growth factors¹ and by providing a slow-resorbing matrix that supports healing across the defect.

B2: Is Bone Grafting Still an Option? Dr. Keener - ASAP Meeting 2020

Bone Graft to the Glenoid Then TSA or RSP: What Does AI Tell Us?

BIO⁴

Viable Bone Matrix

A viable bone matrix containing endogenous bone forming cells (including mesenchymal stem cells, osteoprogenitor cells, and osteoblasts) as well as osteoinductive and angiogenic growth factors

Bone Vac

autologous bone dust collector

Conveniently collects drilled dust for use as autograft material during procedures where bone regeneration is desired.

Augment

Augment is the first and only FDA approved alternative to autograft in hindfoot and ankle arthrodesis backed by the largest prospective Level 1 RCT in Foot and Ankle Orthopedic history. In the randomized, controlled pivotal trial conducted to support U.S. FDA approval of Augment Bone Graft, 75% of the treated patients had one or more risk factors for non-union. Literature reports a range of 10% to as high as 41% of all hindfoot and ankle fusions fail.

Bone Dust Viability

Vitoss

Synthetic Bone Graft

A synthetic bone graft with a unique interconnected, ultra-porous structure that resembles human cancellous bone

Vitoss BiModal

Bioactive Bone Graft Substitute

A synthetic bone graft containing a broader range of bioactive glass particle size distribution than other forms of Vitoss, and has a unique porosity, structure, and chemistry to help drive 3D regeneration of bone

Vitoss BA

Bioactive Bone Graft Substitute

A synthetic bone graft with bioactive glass that has a unique porosity, structure, and chemistry to help drive 3D regeneration of bone

Vitoss BA2X

Bioactive Bone Graft Substitute

A synthetic bone graft that has increased levels of bioactive glass compared to Vitoss BA, and has a unique porosity, structure, and chemistry to help drive 3D regeneration of bone

Allograft Bio Implants

Bone and tissue grafts for craniomaxillofacial procedures

HydroSet XT

Injectable Bone Substitute

An injectable, self-setting bone substitute composed of tetra-calcium phosphate that is formulated to convert to hydroxyapatite, the principal mineral component of bone.

LITe BIO Delivery System

A low profile, single handed, mallet free instrument designed to deliver bone graft material to the spine

AVS TL

PEEK Spacer

Curved posterior lumbar PEEK spacer with a large bone graft chamber and multiple sizing options

BIO⁴

Viable Bone Matrix

A viable bone matrix containing endogenous bone forming cells (including mesenchymal stem cells, osteoprogenitor cells, and osteoblasts) as well as osteoinductive and angiogenic growth factors

AVS Navigator

PEEK Spacer

Steerable posterior lumbar PEEK spacer with a large bone graft chamber and multiple sizing options

SonicPin

Bioresorbable implant

The SonicPin System is intended to maintain alignment and fixation of bone fractures, osteotomies or bone grafts in hallux valgus applications in the presence of appropriate immobilization (e.g. rigid fixation implants, cast and brace.)

Newly Published Data Demonstrate Bone In-Growth Potential of Stryker’s 3D-Printed Tritanium® Cage

Biologics

Stryker’s advantage
Stryker is one of the world’s leading medical technology companies. In order to better partner with our customers, we made the decision to invest in the development of our biologics portfolio to bring a comprehensive solution to a variety of specialties, including orthopaedic, spine, sports medicine, and CMF.

Stryker continues to develop innovative technologies to enhance our spectrum of products, while collaborating with industry-leading tissue organizations to offer a robust portfolio of proprietary spinal grafts, viable bone matrices, demineralized bone matrix products, synthetic bone grafting substitutes, amniotic and dermal membranes, and nerve products.

Our focus on actively bringing new and compelling products to our portfolio is guided by our commitment to both surgeon and patient needs, as well as a quality-first foundation. Stryker works with various heath authorities and regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and organizations like the American Association of Tissue Banks (AATB) to ensure our products meet the appropriate standards.

Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process

Search Results

Showing results for: bone graft